Abstract
To summarise available evidence on the accuracy and the clinical utility, as well as assess the economic aspect of molecular testing (immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), reverse transcription-polymerase chain reaction (RT-PCR) and next-generation sequencing (NGS)) for the identification of NTRK neurotrophic tyrosine receptor kinase (NTRK) gene fusions in patients with locally advanced or metastatic solid tumours.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
